butyraldehyde has been researched along with Liver Failure, Acute in 1 studies
Liver Failure, Acute: A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Z | 1 |
| Zhu, G | 1 |
| Sun, C | 1 |
| Zhang, J | 1 |
| Zhang, Y | 2 |
| Ye, C | 1 |
| Wang, X | 1 |
| Ilghari, D | 1 |
| Li, X | 1 |
1 other study available for butyraldehyde and Liver Failure, Acute
| Article | Year |
|---|---|
A novel solid-phase site-specific PEGylation enhances the in vitro and in vivo biostabilty of recombinant human keratinocyte growth factor 1.
Topics: Aldehydes; Animals; Binding Sites; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cyt | 2012 |